Neimeth International Pharmaceuticals Plc, a manufacturer of and marketer of pharmaceuticals and animal health products has released its statement of profit or loss and other comprehensive income for the year ended 30 September 2020 with turnover for the fourth quarter up by 4.26% to N1 billion from N960.738 million in Q4 2019.
The result released at the Nigerian Stock Exchange showed that turnover for the full year grew to N3 billion from N2.371 billion in 2019.
Profit for the fourth quarter from continued operation dipped by 31.94% to N128.681 million from N189.076 million in Q4 2019.
However, profit for the full year rose by 66.39% to N366.309 million from N220.147 million in 2019.
